Total Payments
$302,323
2024 Payments
$66,579
Companies
36
Transactions
1,062
Medicare Patients
2,600
Medicare Billing
$698,549
Payment Breakdown by Category
Other$237,938 (78.7%)
Consulting$28,101 (9.3%)
Travel$19,472 (6.4%)
Food & Beverage$16,560 (5.5%)
Education$252.73 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $234,359 | 102 | 77.5% |
| Consulting Fee | $28,101 | 12 | 9.3% |
| Travel and Lodging | $19,472 | 75 | 6.4% |
| Food and Beverage | $16,560 | 855 | 5.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,875 | 1 | 0.6% |
| Honoraria | $1,704 | 2 | 0.6% |
| Education | $252.73 | 15 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $195,136 | 278 | $0 (2024) |
| ITI, Inc. | $25,254 | 63 | $0 (2023) |
| Axsome Therapeutics, Inc. | $23,147 | 26 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19,893 | 37 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $17,753 | 109 | $0 (2020) |
| Allergan, Inc. | $8,814 | 67 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $3,514 | 37 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,488 | 7 | $0 (2024) |
| Lundbeck LLC | $1,158 | 100 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $995.84 | 72 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66,579 | 158 | Alkermes, Inc. ($28,148) |
| 2023 | $55,460 | 160 | Alkermes, Inc. ($44,014) |
| 2022 | $45,164 | 116 | Alkermes, Inc. ($26,282) |
| 2021 | $19,186 | 67 | Alkermes, Inc. ($12,846) |
| 2020 | $11,916 | 84 | Alkermes, Inc. ($8,022) |
| 2019 | $52,198 | 200 | Alkermes, Inc. ($38,435) |
| 2018 | $31,243 | 151 | Alkermes, Inc. ($23,405) |
| 2017 | $20,579 | 126 | Alkermes, Inc. ($13,984) |
All Payment Transactions
1,062 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: CNS | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.93 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/20/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,060.00 | General |
| Category: CNS | ||||||
| 11/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $20.10 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Central Nervous System | ||||||
| 11/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: CNS | ||||||
| 10/31/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Travel and Lodging | In-kind items and services | $158.12 | General |
| Category: CNS | ||||||
| 10/28/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Insomnia | ||||||
| 10/16/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: CNS | ||||||
| 10/10/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.58 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $8.04 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 98 | 323 | $61,310 | $22,347 |
| 2022 | 8 | 518 | 1,991 | $407,980 | $157,553 |
| 2021 | 9 | 852 | 3,247 | $653,745 | $251,045 |
| 2020 | 10 | 1,132 | 3,764 | $748,160 | $267,604 |
Total Patients
2,600
Total Services
9,325
Medicare Billing
$698,549
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 173 | $38,060 | $14,757 | 38.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 43 | 150 | $23,250 | $7,590 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 541 | $119,020 | $51,174 | 43.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 75 | 556 | $119,540 | $44,417 | 37.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 59 | 421 | $65,255 | $23,439 | 35.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 76 | 84 | $34,440 | $12,662 | 36.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 58 | 69 | $23,805 | $10,211 | 42.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 50 | 184 | $28,520 | $9,900 | 34.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 60 | 64 | $10,560 | $3,557 | 33.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 37 | 72 | $6,840 | $2,193 | 32.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 147 | 1,140 | $245,100 | $92,014 | 37.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 544 | $119,680 | $53,047 | 44.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 130 | 823 | $127,565 | $46,134 | 36.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 142 | 168 | $68,880 | $25,975 | 37.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 61 | 76 | $26,220 | $11,646 | 44.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 121 | 142 | $23,430 | $7,961 | 34.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 40 | 142 | $22,010 | $7,623 | 34.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 94 | 200 | $19,000 | $5,990 | 31.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 12 | $1,860 | $654.07 | 35.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 190 | 1,311 | $281,305 | $102,860 | 36.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 163 | 923 | $142,810 | $50,219 | 35.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 100 | 444 | $96,546 | $34,631 | 35.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 190 | 219 | $89,610 | $33,255 | 37.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 165 | 185 | $30,390 | $10,092 | 33.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 68 | 83 | $28,499 | $9,737 | 34.2% |
About Dr. Jasjit Singh, MD
Dr. Jasjit Singh, MD is a Psychiatry healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265466197.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jasjit Singh, MD has received a total of $302,323 in payments from pharmaceutical and medical device companies, with $66,579 received in 2024. These payments were reported across 1,062 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($234,359).
As a Medicare-enrolled provider, Singh has provided services to 2,600 Medicare beneficiaries, totaling 9,325 services with total Medicare billing of $698,549. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Shreveport, LA
- Active Since 07/10/2006
- Last Updated 05/12/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1265466197
Products in Payments
- LYBALVI (Drug) $91,574
- ARISTADA (Drug) $66,146
- CAPLYTA (Drug) $45,148
- Aristada 441 mg (Drug) $37,389
- Auvelity (Drug) $23,147
- LATUDA (Drug) $17,753
- VRAYLAR (Drug) $9,266
- REXULTI (Drug) $1,360
- Azstarys (Drug) $510.96
- INGREZZA (Drug) $431.85
- TRINTELLIX (Drug) $419.80
- VYVANSE (Drug) $397.39
- ABILIFY MAINTENA (Drug) $395.07
- INVEGA SUSTENNA (Drug) $303.05
- AUSTEDO (Drug) $255.45
- Austedo XR (Drug) $239.84
- Fanapt (Drug) $156.78
- MYDAYIS (Drug) $149.90
- BRINTELLIX (Drug) $135.31
- COBENFY (Drug) $133.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Shreveport
Dr. Gregory Brown, M.d, M.D
Psychiatry — Payments: $412,954
Psychiatry $412,954
Suresh Sabbenahalli, Md, MD
Psychiatry — Payments: $9,973
Psychiatry $9,973
Dr. Daniel Feeney, M.d, M.D
Psychiatry — Payments: $4,529
Psychiatry $4,529
Kathryn Kennedy, Md, MD
Psychiatry — Payments: $3,662
Psychiatry $3,662
Elizabeth Bright, Aprn, APRN
Psychiatry — Payments: $3,114
Psychiatry $3,114
Anand Bosmia, Md, MD
Psychiatry — Payments: $2,659
Psychiatry $2,659